Minghao Zhao

Title: The Innovations of Minghao Zhao

Introduction

Minghao Zhao is a prominent inventor based in Xinxiang, China. He has made significant contributions to the field of biomedicine, particularly in the development of compounds that target Bruton's Tyrosine Kinase (BTK). His work is crucial for advancing treatments for various diseases, including autoimmune disorders and cancer.

Latest Patents

Minghao Zhao holds a patent for a compound titled "Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors." This patent discloses a compound of formula I or a pharmaceutically acceptable salt, active metabolite, tautomer, stereoisomer, or prodrug thereof as BTK inhibitors. These compounds are useful for treating autoimmune diseases, inflammatory diseases, cancer, and potentially allergies. He has 1 patent to his name.

Career Highlights

Minghao Zhao is associated with Henan Zhiwei Biomedicine Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His expertise in biomedicine has positioned him as a key figure in his field.

Collaborations

Minghao Zhao has collaborated with notable colleagues, including Qingyun Li and Guojie Fan. Their combined efforts contribute to the advancement of biomedical research and innovation.

Conclusion

Minghao Zhao's work exemplifies the impact of innovative thinking in the field of biomedicine. His contributions are paving the way for new treatments that could significantly improve patient outcomes.